|
Press Releases
November 3, 2011
iCardiac Technologies Continues Rapid Growth
October 4, 2011
iCardiac Awarded Four Global Late Stage Studies
September 8, 2011
iCardiac Joins the Cardiac Safety Research Consortium
August 17, 2011
iCardiac Continues to Expand Globally
May 2, 2011
iCardiac Awarded Seven Global Cardiac Safety Studies for Oncology Compounds
April 19, 2011
iCardiac Awarded Patent for Advanced Repolarization Analytics
October 21, 2010
iCardiac Announces Award of a Global Phase III Cardiac Safety Study
August 10, 2010
iCardiac Reports Record Revenue Growth
June 22, 2010
Three Top 20 Pharmaceutical Companies Select iCardiac as Preferred Vendor
April 22, 2010
Another Top 10 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac
March 11, 2010
Top 10 Pharmaceutical Company Awards Comprehensive Cardiac Safety Study
to iCardiac
January 8, 2010
Leading Global CRO Selects iCardiac as Preferred Vendor
December 1, 2009
Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider
of ECG Core Lab Services
November 11, 2009
Top Five International Pharmaceutical Company Awards Comprehensive Cardiac
Safety Study to iCardiac
October 8, 2009
Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study
to iCardiac
September 24, 2009
Leading Biotechnology Company Awards Phase III Cardiac Safety Study
to iCardiac
September 16, 2009
Top 15 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac
September 9, 2009
iCardiac’s COMPAS Analytics Used in Recent New Drug Approval
August 6, 2009
iCardiac Expands Sales and Marketing Team
July 29, 2009
iCardiac Processes Volume of Data Equivalent to One Thousand Traditional
Thorough QT Studies
July 2, 2009
iCardiac Selected by Top 10 Pharmaceutical Company
June 15, 2009
iCardiac Selected for Multiple Cardiac Safety Studies
May 11, 2009
iCardiac’s Highly Automated QTsm Technology Cross-Validated
Against Results from Five Leading ECG Core Laboratories
May 04, 2009
Avoiding False Positives Key Priority in Cardiac Safety Studies
April 1, 2009
iCardiac Applies Advanced Cardiac Safety Biomarkers in Clinical Study
for Top Pharmaceutical Company
February 23, 2009
iCardiac Reports Significant Revenue Growth and Profitability
February 5, 2009
iCardiac's Highly Automated QTsm Technology Now Validated in
Over 10 Clinical QT Studies
January 21, 2009
iCardiac's COMPAS Technology Validated in Peer Reviewed Publication Co-Authored
by FDA and University of Rochester
October 22, 2008
iCardiac Applies Automated Approach to Thorough QT Study for a Leading
Pharmaceutical Company
September 9, 2008
iCardiac Completes Industry’s Largest Validation Study of Highly Automated
QT Analysis
June 12, 2008
iCardiac Joins Prominent Health-Care Policy Organization
May 8, 2008
Former Pfizer Research Fellow Assumes Key Role at iCardiac Technologies
January 23, 2008
iCardiac Announces Development of Next Generation COMPAS 3.0 Software
Platform
November 13, 2007
iCardiac Technologies Raises Funds To Develop Personalized Approach
to Cardiac Safety
November 6, 2007
Network Formed to Tackle Cardiac Safety Challenge
June 25, 2007
iCardiac Appoints Chief Financial Officer
February 15, 2007
iCardiac Appoints Three New Members to the Board of Directors
January 29, 2007
iCardiac Technologies Enters into Cardiac Safety Alliance with Pfizer
January 18, 2007
iCardiac Wins Technology Innovation Of The Year Award
November 7, 2006
iCardiac Technologies Completes Oversubscribed Series A Round
October 17, 2006
iCardiac Moves Into New Corporate Headquarters
October 6, 2006
Trillium Group And New York State Comptroller Announce
Multi-Million Dollar Investment in iCardiac
September 25, 2006
Venture Capital Forum Selects Company for Best Presentation
Award
May 24, 2006
iCardiac, URMC Ink Exclusive Agreement for Breakthrough Medical Technology
May 2, 2006
iCardiac Technologies Appoints Alex Zapesochny as President and COO
In the News
April 2010
iCardiac Identified as a Top 100 Technology Transfer Success Story Along with Google and Cisco
November 24, 2009
UR gets $2.3M for heart study
Chief tech officer at iCardiac Technologies will lead effort
June 25, 2009
Feeling the Beat
Sasha Latypova and Mikael Totterman at iCardiac look at de-risking drug
candidates in early clinical development
March 25th,
2009
Intelligent ECG: Three years after the E14 guidance, Alexandra Latypova
at iCardiac Technologies, Inc investigates new cardiac safety assessment
challenges and potential solutions in European Pharmaceutical Contractor
Spring 2009 Issue
November 1, 2008
Drug Discovery & Development: What Lies Ahead?
November 1, 2008
Drug Research Predictions - iCardiac Technologies
by Drug Discovery & Development
May 21, 2008
In a Heartbeat as seen in Samedan LTD Spring 2008
April
28, 2008
Screen Door is Wide Open as seen in R&D Directions April 2008
January 20, 2008
Strong pulse at iCardiac in Brighton
January 9, 2008
Integrated approach to TQT
November 26, 2007
CenterWatch Profile on Cardiac Safety Network
June 28, 2007
Engineering K12 Center: "Ending Pharmaceutical Heartbreak"
June 1, 2007
Rochester Medicine: “Leadership in Technology Commercialization”
March
2007
Start-Up Magazine (In Vivo Publication): "iCardiac Technologies Inc.
- A Better Rhythm for Drug Development"
|
